scispace - formally typeset
A

Ariel R. Ase

Researcher at Montreal Neurological Institute and Hospital

Publications -  53
Citations -  2382

Ariel R. Ase is an academic researcher from Montreal Neurological Institute and Hospital. The author has contributed to research in topics: Receptor & Dopamine. The author has an hindex of 28, co-authored 53 publications receiving 2106 citations. Previous affiliations of Ariel R. Ase include McGill University & Université de Montréal.

Papers
More filters
Journal ArticleDOI

Functional Evidence that BDNF Is an Anterograde Neuronal Trophic Factor in the CNS

TL;DR: Results indicate that BDNF is anterogradely transported to fibers and terminals of noradrenergic neurons, that anterogsradely secreted BDNF causes activation of TrkB in target regions, and that this secretion has functional consequences for target neuron survival and differentiation.
Journal ArticleDOI

Remote Optogenetic Activation and Sensitization of Pain Pathways in Freely Moving Mice

TL;DR: These findings demonstrate, for the first time, the optical control of nociception and central sensitization in behaving mammals and enables selective activation of the same class of afferents in both in vivo and ex vivo preparations.
Journal ArticleDOI

P2Y12 expression and function in alternatively activated human microglia

TL;DR: In vitro and in situ experiments confirm that P2Y12 is selectively expressed on human microglia and elevated under neuropathologic conditions that promote Th2 responses, such as parasitic CNS infection and suggest a mechanism to selectively target a functionally unique population of myeloid cells in the CNS.
Journal ArticleDOI

Parkin-mediated Monoubiquitination of the PDZ Protein PICK1 Regulates the Activity of Acid-sensing Ion Channels

TL;DR: This work provides a mechanism explaining how defects in parkin-mediated PICK1 monoubiquitination could enhance ASIC activity and thereby promote neurodegeneration in Parkinson's disease.
Journal ArticleDOI

P2X receptor channels in chronic pain pathways.

TL;DR: The contribution of P 2X3, P2X4 and P2x7 receptors to chronic pain is reviewed and the opportunities and challenges associated with the pharmacological manipulation of their function are discussed.